Found 104 articles for: "AI"
Understanding Patient Perspectives on Rosacea: A Cross-Sectional Analysis of the r/Rosacea Forum on Reddit
June 2026 | Volume 25 | Issue 6 | Original Article | 530 | Copyright © June 2026
Background: As the largest online rosacea forum, r/Rosacea, a subreddit hosted on Reddit, provides a unique opportunity to better understand the concerns of rosacea patients.Read MoreFormulary Coverage of Topical Rosacea Therapies in United States Commercial Insurance: A Cross-Sectional Review
June 2026 | Volume 25 | Issue 6 | Editorials | 577 | Copyright © June 2026
Time is Tissue: A Representative Case Report Highlighting the Importance of Early Clinical Diagnosis of Necrotizing Fasciitis
May 2026 | Volume 25 | Issue 5 | Features | 483 | Copyright © May 2026
Diagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders
April 2026 | Volume 25 | Issue 4 | Original Article | 349 | Copyright © April 2026
Background: Artificial intelligence is increasingly applied to dermatology, yet its reliability in clinically high-stakes subspecialty domains such as nail disease remains poorly...
Read MoreObjective Measures Needed: Dermatology Program Directors' Perspectives on the USMLE Step 1 Pass/Fail Transition
April 2026 | Volume 25 | Issue 4 | Original Article | 345 | Copyright © April 2026
Background: Since January 2022, the United States Medical Licensing Examination (USMLE) Step 1 discontinued reporting a 3-digit score. The objective of this study is to share sur...
Read MoreEfficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
March 2026 | Volume 25 | Issue 3 | Original Article | 204 | Copyright © March 2026
Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss on the scalp and body, leading to a reduced quality of life and psychosocial burden for patients. The only US ...
Read MoreManagement of Nail Toxicities From Fibroblast Growth Factor Receptor Inhibitors
March 2026 | Volume 25 | Issue 3 | Original Article | 263 | Copyright © March 2026
Background: Alterations in fibroblast growth factor receptor (FGFR) signaling are present in many malignancies, including urothelial carcinoma, cholangiocarcinoma, and gastrointe...
Read MorePseudo-Psoriatic Nail Dystrophy Associated With Cosmetic Nail Products
March 2026 | Volume 25 | Issue 3 | Original Article | 256 | Copyright © March 2026
Pseudo-psoriatic nail dystrophy, a form of allergic contact dermatitis (ACD) secondary to nail product use, often mimics nail changes associated with psoriasis, leading to diagnostic delays. This...
Read MoreUpdates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review
March 2026 | Volume 25 | Issue 3 | Original Article | 240 | Copyright © March 2026
Androgenetic alopecia (AGA) is a common, progressive form of nonscarring hair loss, affecting both men and women. Its pathogenesis is largely driven by androgenic factors, including elevated dihy...
Read MoreChatGPT and DeepSeek in Dermatologic Practice: Do Artificial Intelligence Models Adhere to Psoriasis Treatment Guidelines?
February 2026 | Volume 25 | Issue 2 | Original Article | 133 | Copyright © February 2026
Background: The integration of artificial intelligence (AI), particularly large language models (LLMs), into healthcare has rapidly expanded. In dermatology, machine learning is ...
Read MoreTopical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants
January 2026 | Volume 25 | Issue 1 | Original Article | 67 | Copyright © January 2026
Background: Topical efinaconazole 10% solution has demonstrated efficacy and safety in two phase 3 trials of onychomycosis. As clinical data for onychomycosis treatments are limi...
Read MoreUnveiling Artificial Intelligence's Diagnostic Power and Challenges in Dermatology for Skin of Color: A Review
January 2026 | Volume 25 | Issue 1 | Editorials | e22 | Copyright © January 2026
Perspectives and Practice Patterns of Dermatologists Using Laser Hair Removal for Hidradenitis Suppurativa
December 2025 | Volume 24 | Issue 12 | Editorials | e71 | Copyright © December 2025
Caffeine Supplementation and Hair: A Systematic Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1070 | Copyright © November 2025
Background: While caffeine has been proposed to stimulate hair growth, its safety and efficacy remain unclear. This systematic review evaluates the effects of caffeine interventi...
Read MoreManagement of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream
November 2025 | Volume 24 | Issue 11 | Case Reports | 1141 | Copyright © November 2025
Introduction: Benign Familial Pemphigus (Hailey-Hailey Disease [HHD]) is a rare chronic condition, with treatments focusing on managing disease symptoms.Case...
Read MoreSAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare
October 2025 | Volume 24 | Issue 10 | Original Article | 1012 | Copyright © October 2025
Background: Atopic dermatitis (AD) is a common heterogeneous disorder that typically starts in infancy and early childhood, is associated with the development of comorbidities, a...
Read MoreAn Exosome Regenerative Complex Plus Microneedling Promotes Hair Growth in Subjects With Self-Perceived Thinning Hair
October 2025 | Volume 24 | Issue 10 | Original Article | 988 | Copyright © October 2025
Thinning hair affects the quality of life of affected men and women but has limited treatment options. A novel technology refines exosomes from stem cells to create a concentrated complex that is...
Read MoreA Qualitative Assessment of Chatbots for Common Dermatologic Conditions
October 2025 | Volume 24 | Issue 10 | Editorials | e60 | Copyright © October 2025
Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia
October 2025 | Volume 24 | Issue 10 | Editorials | e59 | Copyright © October 2025
The Dermatologic Hazards of Nail Product Usage
October 2025 | Volume 24 | Issue 10 | Features | 1051 | Copyright © October 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
